Skip to Main Content

Advertisement

Skip Nav Destination

Risk factors and appropriate therapeutic strategies for thrombotic microangiopathy after allogeneic HSCT

Blood Adv (2020) 4 (13): 3169–3179.
Currently there are no citedby results. Try again later.
Close Modal

or Create an Account

Close Modal
Close Modal

Advertisement